A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)
==========================================================================================================================================================================================

* Georgina V Long
* Reinhard Dummer
* Antoni Ribas
* Igor Puzanov
* Olivier Michielin
* Ari VanderWalde
* Robert HI Andtbacka
* Jonathan Cebon
* Eugenio Fernandez
* Josep Malvehy
* Anthony J Olszanski
* Thomas F Gajewski
* John M Kirkwood
* Olga Kuznetsova
* Lisa Chen
* David R Kaufman
* Jeffrey Chou
* F Stephen Hodi